Tag: pharmaceutical industry news
Lupin Strengthens U.S. Generics Portfolio with FDA Approval for Phytonadione Injectable Emulsion, USP
Global pharmaceutical leader Lupin Limited (Lupin) has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New...
Orsini Partners with Priovant to Support Access to New Dermatomyositis Therapy LISRAYA
Orsini, a specialty pharmacy known for its work in rare disease care, has been named a specialty pharmacy partner for LISRAYA (brepocitinib), a newly...
AstraZeneca Licenses Novel Lung Cancer Drug Zegfrovy in $1.5B Global Deal
AstraZeneca announced a exclusive global license agreement with Dizal Pharmaceutical to develop and commercialize Zegfrovy (sunvozertinib), a highly differentiated, oral irreversible EGFR inhibitor designed for targeted lung cancer...
Government Changes Rules to Make Doing Business Easier for Pharma and Food Companies
In a major step toward trust-based governance, the Government of India has operationalised key reforms under the Jan VishwasAct, 2026. The initiative rationalises minor offences...
Sun Pharma Acquires Checkpoint Therapeutics in ₹2,480 Crore Global Expansion Move
Sun Pharmaceutical Industries Limited, one of the world’s leading pharmaceutical giants, announced a definitive agreement to acquire Checkpoint Therapeutics in a transaction valued at...
Emergency Price Adjustment Approved for Critical Cancer Drugs Amid Raw Material Crisis
In a decisive move to counter critical domestic medicine shortages caused by global macroeconomic headwinds, the Department of Pharmaceuticals (DoP) has granted an in-principle...